This site is intended for health professionals only

Editor’s pick

Noncardiac drug risk framework call
Noncardiac drug risk framework call
Beta-blockers “slow atheroma progression”
Beta-blockers “slow atheroma progression”
AstraZeneca enters RNA interference field
AstraZeneca enters RNA interference field
Search-site analysis reveals interest areas
Search-site analysis reveals interest areas
No gain from clodronate
No gain from clodronate
UK’s NICE issues anaemia consultation
UK’s NICE issues anaemia consultation
Warning on botulinum product risk
Warning on botulinum product risk
Rosuvastatin freed from black triangle
Rosuvastatin freed from black triangle
Avonex administration improvements announced
Avonex administration improvements announced
Fake drug scheme’s sponsor changes
Fake drug scheme’s sponsor changes
GSK in $40m China investment
GSK in $40m China investment
Quality assured every time
Quality assured every time
1 … 254 255 256 257 258 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x